Pathogenesis and current approaches to control of varicella-zoster virus infections

AA Gershon, MD Gershon - Clinical Microbiology Reviews, 2013 - Am Soc Microbiol
AA Gershon, MD Gershon
Clinical Microbiology Reviews, 2013Am Soc Microbiol
Varicella-zoster virus (VZV) was once thought to be a fairly innocuous pathogen. That view
is no longer tenable. The morbidity and mortality due to the primary and secondary diseases
that VZV causes, varicella and herpes zoster (HZ), are significant. Fortunately, modern
advances, including an available vaccine to prevent varicella, a therapeutic vaccine to
diminish the incidence and ameliorate sequelae of HZ, effective antiviral drugs, a better
understanding of VZV pathogenesis, and advances in diagnostic virology have made it …
Summary
Varicella-zoster virus (VZV) was once thought to be a fairly innocuous pathogen. That view is no longer tenable. The morbidity and mortality due to the primary and secondary diseases that VZV causes, varicella and herpes zoster (HZ), are significant. Fortunately, modern advances, including an available vaccine to prevent varicella, a therapeutic vaccine to diminish the incidence and ameliorate sequelae of HZ, effective antiviral drugs, a better understanding of VZV pathogenesis, and advances in diagnostic virology have made it possible to control VZV in the United States. Occult forms of VZV-induced disease have been recognized, including zoster sine herpete and enteric zoster, which have expanded the field. Future progress should include development of more effective vaccines to prevent HZ and a more complete understanding of the consequences of VZV latency in the enteric nervous system.
American Society for Microbiology